Illustration: Aïda Amer/Axios
Life sciences company Verily raised $300 million, with Alphabet remaining a significant minority investor but no longer holding a controlling stake.
Why it matters: Verily has struggled to bring many of its ambitious bets to fruition over its decade-long lifespan.
